INS and AL amyloidosis: Using a data platform29 to analyze more than 15 years of longitudinal EHRs of a US population-based cohort of more than 100 million individuals, we found that in patients with T2D who had no history of any OAC, GLP-1RAs compared with insulins were associated with a significant risk reduction in 10 of 13 OACs, including esophageal, colorectal, kidney, pancreatic, gallbladder, ovarian, endometrial, and liver cancers as well as meningioma and multiple myeloma.